Czernik Marcin

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$22.89M

Insider Activity of Czernik Marcin

The largest sale of all time was on 2014-07-30 and amounted to 126102 shares of Karyopharm Therapeutics Inc. for $4.64M.

Biography of Czernik Marcin

No biography is available at this moment.

2014-09-26SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
100,000
0.3104%
$42.54$4.25M-33.25%
2014-09-24SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
44,996
0.1416%
$40.32$1.81M-28.58%
2014-09-18SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
5,556
0.0173%
$40.16$223,111-28.74%
2014-09-17SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
19,138
0.0597%
$40.26$770,540-28.51%
2014-09-08SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
71,332
0.2167%
$39.92$2.85M-28.99%
2014-09-04SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
25,590
0.0799%
$38.07$974,191-23.28%
2014-08-27SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
42,920
0.1361%
$39.07$1.68M-22.26%
2014-08-26SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
44,478
0.1357%
$38.55$1.71M-24.12%
2014-08-25SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
8,778
0.0272%
$38.08$334,302-22.06%
2014-08-18SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
6,350
0.02%
$39.10$248,264-21.61%
2014-08-15SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
15,654
0.0485%
$39.14$612,718-22.29%
2014-08-14SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
400
0.0012%
$38.04$15,218-20.04%
2014-08-11SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
73,958
0.2259%
$37.30$2.76M-18.58%
2014-07-30SaleKaryopharm Therapeutics Inc.
KPTI
10 percent owner
126,102
0.3964%
$36.81$4.64M-13.37%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.